MAASLens is a research-driven platform dedicated to the systematic monitoring, analysis, and interpretation of antimicrobial use and resistance patterns. Developed under the MAAS initiative, MAASLens aims to support evidence-based decision-making in antimicrobial stewardship, public health, and clinical research.
The system integrates epidemiological methods with advanced data analytics to provide timely, accurate, and actionable insights into the evolving landscape of antimicrobial resistance (AMR).
Mission & Vision
Mission
To strengthen antimicrobial resistance surveillance through high-quality data, robust epidemiological analysis, and transparent reporting, supporting research, policy development, and responsible antimicrobial use.
Vision
MAASLens envisions a future in which antimicrobial resistance is proactively monitored, scientifically understood, and effectively addressed through collaboration, innovation, and data transparency.
What MAASLens Does
Antimicrobial Usage Analysis
Assessment of prescribing and consumption patterns to identify misuse, overuse, and emerging risks.
AMR Surveillance
Continuous monitoring of antimicrobial resistance trends across pathogens, drugs, and geographic regions.
Epidemiological Insights
Application of epidemiological frameworks to understand resistance dynamics, transmission trends, and burden of disease.
Data-Driven Decision Support
Translation of surveillance data into insights for researchers, clinicians, and public health stakeholders.
Key Features
Standardized data collection and reporting
Research-oriented analytical framework
Scalable design for local, national, or global surveillance
Compatibility with public health and academic reporting standards
Support for antimicrobial stewardship initiatives
Who It Serves
Researchers and academic institutions
Public health organizations and policymakers
Healthcare systems and antimicrobial stewardship programs
Surveillance and epidemiology professionals